Piper Sandler Reiterates Overweight on Indivior, Lowers Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst David Amsellem has reiterated an Overweight rating on Indivior (NASDAQ:INDV) but has lowered the price target from $22 to $15.
October 11, 2024 | 2:12 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler has maintained an Overweight rating on Indivior but reduced the price target from $22 to $15, indicating a less optimistic outlook.
The reduction in price target from $22 to $15 suggests a less optimistic view on Indivior's future performance, which could lead to a negative short-term impact on the stock price despite the maintained Overweight rating.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100